• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice.

作者信息

Chong Elaine W, Al-Qureshi Salmaan H

机构信息

Royal Victorian Eye and Ear Hospital and Centre for Eye Research Australia, Melbourne, Victoria, Australia.

出版信息

Clin Exp Ophthalmol. 2017 May;45(4):333-335. doi: 10.1111/ceo.12968.

DOI:10.1111/ceo.12968
PMID:28618455
Abstract
摘要

相似文献

1
Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性:年龄相关性黄斑变性治疗试验5年结果比较及对临床实践的启示
Clin Exp Ophthalmol. 2017 May;45(4):333-335. doi: 10.1111/ceo.12968.
2
Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.阿柏西普治疗抗血管内皮生长因子难治性新生血管性年龄相关性黄斑变性和息肉状脉络膜血管病变
Korean J Ophthalmol. 2015 Aug;29(4):226-32. doi: 10.3341/kjo.2015.29.4.226. Epub 2015 Jul 21.
3
Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.雷珠单抗和贝伐单抗交替双周玻璃体内注射治疗伴有色素上皮脱离的难治性新生血管性年龄相关性黄斑变性
Semin Ophthalmol. 2017;32(3):309-315. doi: 10.3109/08820538.2015.1072222. Epub 2015 Sep 4.
4
Different Clinical Courses on Long-Term Follow-Up of Age-Related Macular Degeneration Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.玻璃体腔内注射抗血管内皮生长因子治疗年龄相关性黄斑变性患者的长期随访不同临床病程
Ophthalmologica. 2017;238(4):217-225. doi: 10.1159/000479437. Epub 2017 Sep 20.
5
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.抗血管内皮生长因子疗法治疗伴有严重视力丧失的新生血管性年龄相关性黄斑变性:临床结果及预后指标
Retina. 2017 Feb;37(2):257-264. doi: 10.1097/IAE.0000000000001150.
6
The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中血管内皮功能障碍与治疗频率的关系
Jpn J Ophthalmol. 2017 Jul;61(4):347-353. doi: 10.1007/s10384-017-0515-z. Epub 2017 Apr 26.
7
Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.抗血管内皮生长因子治疗年龄相关性黄斑变性继发黄斑下出血眼的临床结局
Korean J Ophthalmol. 2015 Oct;29(5):315-24. doi: 10.3341/kjo.2015.29.5.315. Epub 2015 Sep 22.
8
Safety and complications of intravitreal injections performed in an Asian population in Singapore.新加坡亚洲人群玻璃体内注射的安全性与并发症
Int Ophthalmol. 2017 Apr;37(2):325-332. doi: 10.1007/s10792-016-0241-4. Epub 2016 May 28.
9
TREATMENT OUTCOMES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH INITIAL VISION BETTER THAN 20/40 USING A TREAT-AND-EXTEND REGIMEN.采用治疗并延长方案对初始视力优于20/40的新生血管性年龄相关性黄斑变性患者的治疗结果
Retina. 2016 May;36(5):875-80. doi: 10.1097/IAE.0000000000000814.
10
Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.玻璃体黄斑粘连对新生血管性年龄相关性黄斑变性抗血管内皮生长因子治疗的影响。
Ophthalmic Res. 2017;58(1):18-26. doi: 10.1159/000459626. Epub 2017 Mar 17.

引用本文的文献

1
Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.用于治疗新生血管性年龄相关性黄斑变性的抗血管内皮生长因子药物给药治疗方案。
Cochrane Database Syst Rev. 2020 May 5;5(5):CD012208. doi: 10.1002/14651858.CD012208.pub2.